Read More Pharma Industry News Otsuka’s Astex signs $490m-plus Genentech breast cancer partnership Astex signs a $490 million-plus Genentech breast cancer deal. Discover how Otsuka’s fragment platform could reshape Roche oncology research and returns. bySrinathJuly 8, 2026